Experts outline what it takes to build a sustainable CGT program, from governance and SOPs to navigating complex reimbursement landscapes.
Elias Pittos, PharmD
Advertisement
Elias Pittos, PharmD, BCOP, CSP, is the medical director of cell, gene, and advanced therapies at McKesson in Chicago.
Articles by Elias Pittos, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
GLP-1 Plus Glucagon: The Mechanistic Case for Dual Receptor Agonism in Obesity and MASH
2
FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success
3
Rituximab Matches Ocrelizumab in Head-to-Head MS Trial
4
$20 Billion National Strategy Aims to Close the Women's Health Gap
5